Systems biology approach to study metabolic syndrome (2016)
- Authors:
- USP affiliated authors: HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; HIRATA, MARIO HIROYUKI - FCF ; NAKAYA, HELDER TAKASHI IMOTO - FCF
- Unidade: FCF
- Assunto: SÍNDROME X METABÓLICA
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Imunologia/SBI
- Publisher place: São Paulo
- Date published: 2016
- Source:
- Título: Abstracts
- Conference titles: Congress of the Brazilian Society of Immunology
-
ABNT
HIRATA, Thiago Dominguez Crespo et al. Systems biology approach to study metabolic syndrome. 2016, Anais.. São Paulo: Sociedade Brasileira de Imunologia/SBI, 2016. . Acesso em: 06 maio 2026. -
APA
Hirata, T. D. C., Hirata, R. D. C., Hirata, M. H., Russo, P. de S. T., Ferreira, G. R., Bürger, M. C., & Nakaya, H. T. I. (2016). Systems biology approach to study metabolic syndrome. In Abstracts. São Paulo: Sociedade Brasileira de Imunologia/SBI. -
NLM
Hirata TDC, Hirata RDC, Hirata MH, Russo P de ST, Ferreira GR, Bürger MC, Nakaya HTI. Systems biology approach to study metabolic syndrome. Abstracts. 2016 ;[citado 2026 maio 06 ] -
Vancouver
Hirata TDC, Hirata RDC, Hirata MH, Russo P de ST, Ferreira GR, Bürger MC, Nakaya HTI. Systems biology approach to study metabolic syndrome. Abstracts. 2016 ;[citado 2026 maio 06 ] - Differentially expressed miRNAs are potential biomarkers for poor response to dual antiplatelet therapy in patients with coronary arterial disease
- Ultrassequenciamento exômico dos genes LDLR, APOB, PCSK9 e APOE em pacientes com hipercolesterolemia familiar
- miR-183-5P e miR-421 como biomarcadores epigenéticos precoces da Síndrome Metabólica
- Involvement of TLR2 and TLR4, Chlamydophila pneumoniae and mycoplasma pneumoniae in adventitial inflammation of aortic atherosclerotic aneurysm
- Interferon-'alfa' receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-a therapy of patients with chronic hepatitis C
- Atorvastatina regula negativamente la expresión de microRNAs en individuos hipercolesterolémicos
- IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus
- Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus
- Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina
- Expression of ppargamma, ppargamma2, SUR1 and KIR6.2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
